Genesis Molecular AI · Series B
Generative AI for small-molecule drug discovery
Amount
$200M
Round
Series B
Valuation
—
Announced
Aug 2023
Investors
Lead investor
Participating investors
Generative AI for small-molecule drug discovery
Amount
$200M
Round
Series B
Valuation
—
Announced
Aug 2023
Lead investor
Participating investors